Enanta Pharmaceuticals, Inc. (ENTA)
11.10
-0.37
(-3.23%)
USD |
NASDAQ |
Oct 16, 16:00
11.12
+0.02
(+0.18%)
After-Hours: 20:00
Enanta Pharmaceuticals Cash and Short Term Investments (Quarterly) : 189.51M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 189.51M |
| March 31, 2026 | 163.77M |
| December 31, 2025 | 185.85M |
| September 30, 2025 | 188.86M |
| June 30, 2025 | 204.11M |
| March 31, 2025 | 193.38M |
| December 31, 2024 | 217.30M |
| September 30, 2024 | 248.79M |
| June 30, 2024 | 230.69M |
| March 31, 2024 | 300.31M |
| December 31, 2023 | 337.15M |
| September 30, 2023 | 369.91M |
| June 30, 2023 | 386.58M |
| March 31, 2023 | 210.08M |
| December 31, 2022 | 214.47M |
| September 30, 2022 | 249.23M |
| June 30, 2022 | 253.29M |
| March 31, 2022 | 280.33M |
| December 31, 2021 | 259.05M |
| September 30, 2021 | 244.00M |
| June 30, 2021 | 256.82M |
| March 31, 2021 | 375.95M |
| December 31, 2020 | 386.20M |
| September 30, 2020 | 386.65M |
| June 30, 2020 | 370.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 355.26M |
| December 31, 2019 | 373.78M |
| September 30, 2019 | 335.24M |
| June 30, 2019 | 389.25M |
| March 31, 2019 | 370.16M |
| December 31, 2018 | 345.79M |
| September 30, 2018 | 308.73M |
| June 30, 2018 | 273.23M |
| March 31, 2018 | 256.72M |
| December 31, 2017 | 220.44M |
| September 30, 2017 | 223.67M |
| June 30, 2017 | 192.02M |
| March 31, 2017 | 175.57M |
| December 31, 2016 | 209.36M |
| September 30, 2016 | 210.08M |
| June 30, 2016 | 218.46M |
| March 31, 2016 | 220.42M |
| December 31, 2015 | 180.02M |
| September 30, 2015 | 145.20M |
| June 30, 2015 | 154.29M |
| March 31, 2015 | 165.47M |
| December 31, 2014 | 104.02M |
| September 30, 2014 | 90.76M |
| June 30, 2014 | 95.89M |
| March 31, 2014 | 94.77M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 236.88M |
| Coherus Oncology, Inc. | 105.31M |
| BridgeBio Pharma, Inc. | 720.71M |
| RenovoRx, Inc. | 9.479M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |